Gain Therapeutics, Inc. - Common Stock (NQ:GANX)
Price and Volume
Detailed Quote| Volume | 1 |
| Open | 2.950 |
| Bid (Size) | 2.820 (100) |
| Ask (Size) | 3.120 (1,000) |
| Prev. Close | 2.950 |
| Today's Range | 2.950 - 2.950 |
| 52wk Range | 1.410 - 3.030 |
| Shares Outstanding | 27,132,588 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
October 16, 2025
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
September 23, 2025
12 Health Care Stocks Moving In Friday's After-Market Session ↗
August 08, 2025
Tuesday's after hours session: top gainers and losers ↗
July 15, 2025
Gain Therapeutics Announces Proposed Public Offering
July 15, 2025
Frequently Asked Questions
Is Gain Therapeutics, Inc. - Common Stock publicly traded?
Yes, Gain Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Gain Therapeutics, Inc. - Common Stock trade on?
Gain Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Gain Therapeutics, Inc. - Common Stock?
The ticker symbol for Gain Therapeutics, Inc. - Common Stock is GANX on the Nasdaq Stock Market
What is the current price of Gain Therapeutics, Inc. - Common Stock?
The current price of Gain Therapeutics, Inc. - Common Stock is 2.950
When was Gain Therapeutics, Inc. - Common Stock last traded?
The last trade of Gain Therapeutics, Inc. - Common Stock was at 11/12/25 04:00 PM ET
What is the market capitalization of Gain Therapeutics, Inc. - Common Stock?
The market capitalization of Gain Therapeutics, Inc. - Common Stock is 80.04M
How many shares of Gain Therapeutics, Inc. - Common Stock are outstanding?
Gain Therapeutics, Inc. - Common Stock has 80M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.